Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Treatment With Aldosterone Antagonism Attenuates Cardiomyopathy in Duchenne Muscular Dystrophy

NCT01521546 is registered in ClinicalTrials.gov with Subha Raman as lead sponsor.

NCT NCT01521546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01521546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Treatment With Aldosterone Antagonism Attenuates Cardiomyopathy in Duchenne Muscular Dystrophy
Lead sponsor
Subha Raman
Phase
Not applicable
Overall status
Completed
Start date
February 29, 2012
Completion date
June 30, 2016
Enrollment
42 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

duchenne muscular dystrophy